Correlation Between Bristol Myers and Addex Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Addex Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Addex Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Addex Therapeutics, you can compare the effects of market volatilities on Bristol Myers and Addex Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Addex Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Addex Therapeutics.
Diversification Opportunities for Bristol Myers and Addex Therapeutics
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Bristol and Addex is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Addex Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Addex Therapeutics and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Addex Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Addex Therapeutics has no effect on the direction of Bristol Myers i.e., Bristol Myers and Addex Therapeutics go up and down completely randomly.
Pair Corralation between Bristol Myers and Addex Therapeutics
Considering the 90-day investment horizon Bristol Myers is expected to generate 2.49 times less return on investment than Addex Therapeutics. But when comparing it to its historical volatility, Bristol Myers Squibb is 3.91 times less risky than Addex Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Addex Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 937.00 in Addex Therapeutics on September 1, 2024 and sell it today you would lose (66.00) from holding Addex Therapeutics or give up 7.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Addex Therapeutics
Performance |
| Timeline |
| Bristol Myers Squibb |
| Addex Therapeutics |
Bristol Myers and Addex Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Addex Therapeutics
The main advantage of trading using opposite Bristol Myers and Addex Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Addex Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will offset losses from the drop in Addex Therapeutics' long position.| Bristol Myers vs. Crinetics Pharmaceuticals | Bristol Myers vs. Enanta Pharmaceuticals | Bristol Myers vs. Amicus Therapeutics | Bristol Myers vs. Connect Biopharma Holdings |
| Addex Therapeutics vs. Innate Pharma | Addex Therapeutics vs. Aptorum Group Ltd | Addex Therapeutics vs. Dyadic International | Addex Therapeutics vs. Soligenix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |